19F-MRI in vivo determination of the partial oxygen pressure in perfluorocarbon-loaded alginate capsules implanted into the peritoneal cavity and different tissues

Magnetic Resonance in Medicine

Volumn 42, Issue 6, 1999, Pages 1039-1047

  Nöth, Ulrike ^a,b   Gröhn, Patrik ^c   Jork, Anette ^c   Zimmermann, Ulrich ^c   Haase, Axel ^a   Lutz, Joachim ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c Biozentrum   (Germany)

Author keywords

19F MRI; Alginate; Partial oxygen pressure (pO2); Transplantation

Indexed keywords

ALGINATE; BIOCOMPATIBILITY; HISTOLOGY; RATS; TISSUE; TRANSPLANTATION (SURGICAL);

ALGINATE CAPSULES; ALGINATE SOLUTIONS; ENCAPSULATED CELL; ENCAPSULATED MATERIALS; IMPLANTATION SITES; METABOLIC ACTIVITY; PARTIAL OXYGEN PRESSURES; TEMPORAL BEHAVIOR;

OXYGEN SUPPLY;

ALGINIC ACID; BARIUM ION; FLUOROCARBON; OXYGEN; BIOMATERIAL; DRUG CARRIER; FLUORINE; GLUCURONIC ACID; HEXURONIC ACID;

ANIMAL EXPERIMENT; ARTICLE; FEMALE; HYDROGEL; KIDNEY CAPSULE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXYGEN SUPPLY; OXYGEN TENSION; PERITONEAL CAVITY; QUADRICEPS FEMORIS MUSCLE; RAT; TISSUE METABOLISM; ANIMAL; KIDNEY; METABOLISM; MICROCAPSULE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESSURE; SKELETAL MUSCLE; WISTAR RAT;

ALGINATES; ANIMALS; BIOCOMPATIBLE MATERIALS; CAPSULES; DRUG CARRIERS; FEMALE; FLUORINE; FLUOROCARBONS; GLUCURONIC ACID; HEXURONIC ACIDS; KIDNEY; MAGNETIC RESONANCE IMAGING; MUSCLE, SKELETAL; OXYGEN; PARTIAL PRESSURE; PERITONEAL CAVITY; RATS; RATS, WISTAR;

EID: 85047678174     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2594(199912)42:6<1039::AID-MRM8>3.3.CO;2-E     Document Type: Article

References (39)

1. 2+-alginate-coated islets of Langerhans for immunoisolation. Exp Clin Endocrinol 1994;102:380-387.
2. Zekorn T, Horcher A, Siebers U, Schnettler R, Klöck G, Hering B, Zimmermann U, Bretzel RG, Federlin K. Barium-cross-linked alginate beads: a simple, one-step method for successful immuno-isolated transplantation of islets of Langerhans. Acta Diabetol 1992;29:99-106.
3. Clayton HA, James RFL, London NJM. Islet microencapsulation: a review. Acta Diabetol 1993;30:181-189.
4. Sun Y, Ma X, Zhou D, Vacek I, Sun AM. Normalization of diabetes in spontaneously diabetic cynomolgus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest 1996;98:1417-1422.
5. Hasse C, Klöck G, Schlosser A, Zimmermann U, Rothmund M. Parathyroid allotransplantation without immunosuppression. Lancet 1997;350; 1296-1297.
6. Parhami P, Fung BM. Fluorine-19 relaxation study of perfluoro chemicals as oxygen carriers. J Phys Chem 1983;87:1928-1931.
7. 19F MRI of sequestered perfluorocarbon. Magn Reson Med 1996;35:827-833.
8. Webb AG, Wong M, Kolbeck KJ, Magin RL, Suslick KS. Sonochemically produced fluorocarbon microspheres: a new class of magnetic resonance imaging agent. J Magn Reson Imag 1996;6:675-683.
9. 2. Invest Radiol 1997;32:29-38.
10. Lutz J, Stark M. Half life and changes in the composition of a perfluorochemical emulsion within the vascular system of rats. Pflügers Arch 1987;410:181-134.
11. Mattrey RF, Long DM, Multer F, Mitten R, Higgins CB. Perfluoroctylbromide: a reticuloendothelial-specific and tumor-imaging agent for computed tomography. Radiology 1982;145:755-758.
12. 19F magnetic resonance imaging of the reticuloendothelial system. Magn Reson Med 1987;5:548-554.
13. 19F NMR. Magn Reson Med 1993;29:446-458.
14. 19F-NMR imaging in vivo using FLASH-MRI. Magn Reson Imaging 1994;12:149-153.
15. 19F NMR relaxometry of a perfluorocarbon emulsion. Magn Reson Med 1993;29:303-310.
16. 19F inversion-recovery echo-planar imaging of perfluoro-15-crown-5-ether. Magn Reson Med 1994;32:88-97.
17. Mason RP, Antich PP, Babcock EE, Constantinescu A, Peschke P, Hahn EW. Non-invasive determination of tumor oxygen tension and local variation with growth. Int J Radiat Oncol Biol Phys 1994;29:95-103.
18. Nöth U, Morrissey SP, Deichmann R, Jung S, Adolf H, Haase A, Lutz J. Perfluoro-15-crown-5-ether labelled macrophages in adoptive transfer experimental allergic encephalomyelitis. Artif Cells Blood Substit Immobil Biotechnol 1997;25:243-254.
19. Geyer RP. PFC as blood substitutes - an overview. In: Bolin RB, Geyer RP, Nemo GJ, editors. Progress in clinical and biological research, vol 122: advances in blood substitute research. New York: Alan R Liss; 1983. p 157-168.
20. Riess JG, Le Blanc M. Solubility and transport phenomena in perfluorochemicals relevant to blood substitution and other biomedical applications. Pure Appl Chem 1982;54:2383-2406.
21. 19F-MRI of neat PFC droplets. Adv Exp Med Biol 1997;428:569-572.
22. 19F NMR. Magn Reson Med 1991;21:233-241.
23. Wilson CA, Berkowitz BA, Hatchell DL. Oxygen kinetics in preretinal perfluorotributylamine. Exp Eye Res 1992;55:119-126.
24. 19F NMR spectroscopy of hexafluorobenzene. Int J Radial Oncol Biol Phys 1998;41:161-171.
25. Lutz J, Kettemann M, Rácz I, Nöth U. Several methods utilized for the assessment of biocompatibility of perfluorochemicals. Artif Cells Blood Substit Immobil Biotechnol 1995;23:407-415.
26. Klöck G, Frank H, Houben R, Zekorn T, Horcher A, Siebers U, Wöhrle M, Federlin K, Zimmermann U. Production of purified alginates suitable for use in immunoisolated transplantation. Appl Microbiol Biotechnol 1994;40:638-643.
27. 19F-MRI and a new method for the suppression of chemical shift artifacts. J Magn Reson B 1994;105:233-237.
28. 19F-MRI. Magn Reson Med 1995;34:738-745.
29. Deichmann R, Haase A. Quantification of T1 values by snapshot-flash NMR imaging. J Magn Reson 1992;96:608-612.
30. Traficante DD. Relaxation: an introduction. In: Grant DM, Harris RK, editors. Encyclopedia of nuclear magnetic resonance. Chichester, UK: Wiley; 1996. p 3988-4003.
31. Esch M, Sukhorukov VL, Kürschner M, Zimmermann U. Dielectric properties of alginate heads and bound water relaxation studied by electrorotation. Biopolymers 1999;50:227-237.
32. Lai C-S, Stair SJ, Miziokro H, Hyde JS. Effect of oxygen and the lipid spin label TEMPO-laureate on fluorine-19 and proton relaxation rates of the perfluorochemical blood substitute FC-43 emulsion. J Magn Reson 1984;57:447-452.
33. 19F NMR probes of oxygen tension and temperature. J Magn Reson B 1995;106:131-141.
34. 19F NMR indicator of tumor oxygenation. NMR Biomed 1996;9:125-134.
35. Gadian DG. Nuclear magnetic resonance and its applications to living systems. Oxford: Clarendon Press; 1982. 115 p.
36. 19F NMR spectroscopy of perfluorocarbon. Magn Reson Med 1993;29:296-302.
37. Barker BR, Mason RP, Bansal N, Peshock RM. Oxygen tension mapping by F-19 echo-planar MR imaging of sequestered perfluorocarbon. J Magn Reson Imag 1994;4:595-602.
38. Zekorn T, Siebers U, Bretzel RG, Heller S, Meder U, Ruttkay H, Zimmermann U, Federlin K. Impact of the perfluorochemical FC43 on function of isolated islets. A preliminary report. Horm Metab Res 1991;23:302-303.
39. McGovern KA, Schoeniger JS, Wehrle JP, Ng CE, Glickson JD. Gel-entrapment of perfluorocarbons: a fluorine-19 NMR spectroscopic method for monitoring oxygen concentration in cell perfusion systems. Magn Reson Med 1993;29:196-204.